Tuesday, July 1, 2025 7/1/2025

Characterizing the nuclear pore complex-T cell receptor connection

Award Number: R01AI148668
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/16/2019
PERIOD OF PERFORMANCE END DATE: 02/28/2025

Group Awards By:

View Award Description

Characterizing the nuclear pore complex-T cell receptor connection - PROJECT SUMMARY Nuclear pore complexes (NPCs) are large multiprotein channels that connect the nucleus with the cytoplasm. In addition to their role in controlling nucleocytoplasmic transport, NPCs play key roles in gene expression regulation. The molecular mechanisms employed by NPCs and its components (nucleoporins) to regulate gene expression in mammalian cells are still poorly understood. Recent evidence indicates that NPCs have important functions in the immune system. CD4+ T lymphocytes are central players of the adaptive immune response. These cells assist B cells with antibody production, help CD8+ T lymphocytes to clear infections and to control tumor growth, stimulate macrophage activity, recruit immune cells to sites of active infection and inflammation, and exert regulatory roles that are essential to control the extent of the immune response. CD4+ T lymphocytes activate through the stimulation of their T cell receptor (TCR) at the plasma membrane. TCR engagement results in the initiation of the TCR signaling cascade that regulates T cell activation, proliferation, function and survival. We recently identified that the nuclear pore complex component Nup210 has a critical role in the transmission of TCR signals, and in the activation and survival of CD4+ T cells. We found that Nup210 regulates T cell activation by modulating gene expression in response to TCR stimulation. Our findings suggest that a coordinated activity between the plasma membrane and the nuclear envelope is required for the proper transmission of TCR signals and the efficient expression of TCR-induced genes. In this proposal we aim to establish how the TCR stimulation signal is communicated from the plasma membrane to Nup210 at NPCs (Aim 1), to dissect how Nup210 regulates the transcriptional activity NFAT and STAT transcription factors during TCR signaling (Aim 2), and to uncover the role of the Caveolin 2 protein in Nup210-regulation of TCR-induced gene expression (Aim 3). Besides offering novel insights into the mechanisms of gene expression modulation by nucleoporins, we expect our work will result in the characterization of a new mechanism of regulation of T cell function that could potentially be exploited to modulate T cell activity in immune-based therapies.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2024	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE	10901 N TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Allergy and Infectious Diseases Research	000	5	4/23/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $653,587 )
2024	2024	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE	10901 N TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Allergy and Infectious Diseases Research	001	5	5/16/2024	NON-COMPETING CONTINUATION	$65,358
2024	2024	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE	10901 N TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Allergy and Infectious Diseases Research	000	5	11/15/2023	NON-COMPETING CONTINUATION	$588,229
														Subtotal = $653,587

Issue Date FY: 2023 ( Subtotal = $653,587 )
2023	2023	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE	10901 NORTH TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Allergy and Infectious Diseases Research	000	4	11/15/2022	NON-COMPETING CONTINUATION	$653,587
														Subtotal = $653,587

Issue Date FY: 2022 ( Subtotal = $653,587 )
2022	2022	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE	10901 NORTH TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Allergy and Infectious Diseases Research	000	3	10/29/2021	NON-COMPETING CONTINUATION	$653,587
														Subtotal = $653,587

Issue Date FY: 2021 ( Subtotal = $653,587 )
2021	2021	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE	10901 NORTH TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Allergy and Infectious Diseases Research	000	2	11/17/2020	NON-COMPETING CONTINUATION	$653,587
														Subtotal = $653,587

Issue Date FY: 2020 ( Subtotal = $647,737 )
2020	2020	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE	10901 NORTH TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Allergy and Infectious Diseases Research	000	1	12/16/2019	NEW	$647,737
														Subtotal = $647,737

Grand Total All Awards = $3,262,085

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Characterizing the nuclear pore complex-T cell receptor connection

Award Number: R01AI148668

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/16/2019

PERIOD OF PERFORMANCE END DATE: 02/28/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer